Express News | Liquidia- Intends to Defend Its Ability to Launch Yutrepia & to Defend Itself Against United's Allegations
Liquidia Says U.S. Court Found United Therapeutics Caused Losses of More Than $137M
Court Finds United Therapeutics' Interference With Launch of Generic Treprostinil Injection Caused Losses Of More Than $137M
Is United Therapeutics Corporation's (NASDAQ:UTHR) Recent Stock Performance Tethered To Its Strong Fundamentals?
United Therapeutics Publishes Its 2024 Corporate Responsibility and Public Benefit Report Highlighting Its Progress Toward a Future Where No Patient Gets Left Behind—Ever
United Therapeutics Insider Sold Shares Worth $2,821,050, According to a Recent SEC Filing